Misplaced Pages

Oxycodone

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
#844155

115-470: Oxycodone , sold under the brand name Roxicodone and OxyContin (which is the extended-release form) among others, is a semi-synthetic opioid used medically for treatment of moderate to severe pain . It is highly addictive and is a commonly abused drug . It is usually taken by mouth , and is available in immediate-release and controlled-release formulations. Onset of pain relief typically begins within fifteen minutes and lasts for up to six hours with

230-608: A laxative or enemas . Treatment of OIC is successional and dependent on severity. The first mode of treatment is non-pharmacological, and includes lifestyle modifications like increasing dietary fiber , fluid intake (around 1.5 L (51 US fl oz) per day), and physical activity . If non-pharmacological measures are ineffective, laxatives , including stool softeners ( e.g. , polyethylene glycol ), bulk-forming laxatives ( e.g. , fiber supplements ), stimulant laxatives ( e.g. , bisacodyl , senna ), and/or enemas , may be used. A common laxative regimen for OIC

345-608: A laxative or enemas . Treatment of OIC is successional and dependent on severity. The first mode of treatment is non-pharmacological, and includes lifestyle modifications like increasing dietary fiber , fluid intake (around 1.5 L (51 US fl oz) per day), and physical activity . If non-pharmacological measures are ineffective, laxatives , including stool softeners ( e.g. , polyethylene glycol ), bulk-forming laxatives ( e.g. , fiber supplements ), stimulant laxatives ( e.g. , bisacodyl , senna ), and/or enemas , may be used. A common laxative regimen for OIC

460-536: A thebaine input into other opiates and opioids. Oxycodone and/or its major metabolites may be measured in blood or urine to monitor for clearance , non-medical use, confirm a diagnosis of poisoning or assist in a medicolegal death investigation. Many commercial opiate screening tests cross-react appreciably with oxycodone and its metabolites, but chromatographic techniques can easily distinguish oxycodone from other opiates. Martin Freund and (Jakob) Edmund Speyer of

575-403: A CYP3A4 inducer, dramatically reducing the analgesic effects of oxycodone in a chronic pain patient. Dosage or medication adjustments may be necessary in each case. Oxycodone, a semi-synthetic opioid, is a highly selective full agonist of the μ-opioid receptor (MOR). This is the main biological target of the endogenous opioid neuropeptide β-endorphin . Oxycodone has low affinity for

690-447: A [8-hourly] dosing regimen." Purdue repeatedly released memos to its sales representatives ordering them to remind doctors not to deviate from a 12-hour dosing schedule. One such memo read, "There is no Q8 dosing with OxyContin... [8-hour dosing] needs to be nipped in the bud. NOW!!" The journalists who covered the investigation argued that Purdue Pharma has insisted on a 12-hour duration of action for nearly all patients, despite evidence to

805-427: A dose of conventional (immediate-release) oral oxycodone, the onset of action is 10 to 30 minutes, and peak plasma levels of the drug are attained within roughly 30 to 60 minutes; in contrast, after a dose of OxyContin (an oral controlled-release formulation), peak plasma levels of oxycodone occur in about three hours. The duration of instant-release oxycodone is 3 to 6 hours, although this can be variable depending on

920-626: A hydroxyl group at carbon-14. In terms of biosynthesis, oxycodone has been found naturally in nectar extracts from the orchid family Epipactis helleborine ; together along with another opioid: 3-{2-{3-{3-benzyloxypropyl}-3-indol, 7,8-didehydro- 4,5-epoxy-3,6-d-morphinan. Thodey et al. , 2014 introduces a microbial compound manufacturing system for compounds including oxycodone. The Thodey platform produces both natural and semisynthetic opioids including this one. This system uses Saccharomyces cerevisiae with transgenes from Papaver somniferum (the opium poppy) and Pseudomonas putida to turn

1035-544: A minor role, being responsible for 15.8% and 4.5% of the analgesic effect of oxycodone after oral and intravenous administration, respectively. Although the CYP2D6 genotype and the route of administration result in differential rates of oxymorphone formation, the unchanged parent compound remains the major contributor to the overall analgesic effect of oxycodone. In contrast to oxycodone and oxymorphone, noroxycodone and noroxymorphone, while also potent MOR agonists, poorly cross

1150-791: A non-oral route ( e.g. subcutaneous for metoclopramide, rectally for domperidone). Evidence suggests that opioid-inclusive anaesthesia is associated with postoperative nausea and vomiting. Patients with chronic pain using opioids had small improvements in pain and physically functioning and increased risk of vomiting. Tolerance to drowsiness usually develops over 5–7 days, but if troublesome, switching to an alternative opioid often helps. Certain opioids such as fentanyl , morphine and diamorphine (heroin) tend to be particularly sedating, while others such as oxycodone , tilidine and meperidine (pethidine) tend to produce comparatively less sedation, but individual patients responses can vary markedly and some degree of trial and error may be needed to find

1265-791: A non-oral route ( e.g. subcutaneous for metoclopramide, rectally for domperidone). Evidence suggests that opioid-inclusive anaesthesia is associated with postoperative nausea and vomiting. Patients with chronic pain using opioids had small improvements in pain and physically functioning and increased risk of vomiting. Tolerance to drowsiness usually develops over 5–7 days, but if troublesome, switching to an alternative opioid often helps. Certain opioids such as fentanyl , morphine and diamorphine (heroin) tend to be particularly sedating, while others such as oxycodone , tilidine and meperidine (pethidine) tend to produce comparatively less sedation, but individual patients responses can vary markedly and some degree of trial and error may be needed to find

SECTION 10

#1732787763845

1380-489: A range of 60 to 87%, with rectal administration yielding the same results; Intranasal administration of oxycodone has a bioavailability of ~77%, the same half life as oral oxycodone, along with faster Tmax previously reported as 47% for nasal spray administration due to the solution in the study exceeding the 0.3- to 0.4-mL nasal mucosa limit. Buccal bioavailability ~55%, Tmax ~60 min. Sublingual bioavailability 20% (non alkalized) ~55% (alkalized) Tmax ~60 minutes. After

1495-523: A successful long-term care strategy for those with chronic cancer pain . Just over half of all states in the US have enacted laws that restrict the prescribing or dispensing of opioids for acute pain. Guidelines have suggested that the risk of opioids is likely greater than their benefits when used for most non-cancer chronic conditions including headaches , back pain , and fibromyalgia . Thus they should be used cautiously in chronic non-cancer pain. If used

1610-475: A successful long-term care strategy for those with chronic cancer pain . Just over half of all states in the US have enacted laws that restrict the prescribing or dispensing of opioids for acute pain. Guidelines have suggested that the risk of opioids is likely greater than their benefits when used for most non-cancer chronic conditions including headaches , back pain , and fibromyalgia . Thus they should be used cautiously in chronic non-cancer pain. If used

1725-508: A synergistic pain relieving effect permitting smaller doses of opioids be used. Consequently, several opioid/antihistamine combination products have been marketed, such as Meprozine ( meperidine / promethazine ) and Diconal ( dipipanone / cyclizine ), and these may also reduce opioid induced nausea. Opioid-induced constipation (OIC) develops in 90 to 95% of people taking opioids long-term. Since tolerance to this problem does not generally develop, most people on long-term opioids need to take

1840-508: A synergistic pain relieving effect permitting smaller doses of opioids be used. Consequently, several opioid/antihistamine combination products have been marketed, such as Meprozine ( meperidine / promethazine ) and Diconal ( dipipanone / cyclizine ), and these may also reduce opioid induced nausea. Opioid-induced constipation (OIC) develops in 90 to 95% of people taking opioids long-term. Since tolerance to this problem does not generally develop, most people on long-term opioids need to take

1955-795: A variety of effects, including pain relief. As a class of substances, they act on opioid receptors to produce morphine -like effects. The terms 'opioid' and 'opiate' are sometimes used interchangeably, but there are key differences based on the manufacturing processes of these medications. Medically they are primarily used for pain relief , including anesthesia . Other medical uses include suppression of diarrhea , replacement therapy for opioid use disorder , reversing opioid overdose , and suppressing cough . Extremely potent opioids such as carfentanil are approved only for veterinary use. Opioids are also frequently used recreationally for their euphoric effects or to prevent withdrawal . Opioids can cause death and have been used for executions in

2070-498: Is eliminated in the urine 10% as unchanged oxycodone, 45% ± 21% as N -demethylated metabolites (noroxycodone, noroxymorphone, noroxycodols), 11 ± 6% as O -demethylated metabolites (oxymorphone, oxymorphols), and 8% ± 6% as 6-keto-reduced metabolites (oxycodols). Oral oxycodone has a half-life of 4.5 hours. It is available as a generic medication . The manufacturer of OxyContin, a controlled-release preparation of oxycodone, Purdue Pharma , claimed in their 1992 patent application that

2185-495: Is a peripherally selective opioid available without a prescription used to suppress diarrhea. The ability to suppress diarrhea also produces constipation when opioids are used beyond several weeks. Naloxegol , a peripherally-selective opioid antagonist is now available to treat opioid induced constipation. Opioids may help with shortness of breath particularly in advanced diseases such as cancer and COPD among others. However, findings from two recent systematic reviews of

2300-495: Is a peripherally selective opioid available without a prescription used to suppress diarrhea. The ability to suppress diarrhea also produces constipation when opioids are used beyond several weeks. Naloxegol , a peripherally-selective opioid antagonist is now available to treat opioid induced constipation. Opioids may help with shortness of breath particularly in advanced diseases such as cancer and COPD among others. However, findings from two recent systematic reviews of

2415-508: Is a process characterized by neuroadaptations that result in reduced drug effects. While receptor upregulation may often play an important role other mechanisms are also known. Tolerance is more pronounced for some effects than for others; tolerance occurs slowly to the effects on mood, itching, urinary retention, and respiratory depression, but occurs more quickly to the analgesia and other physical side effects. However, tolerance does not develop to constipation or miosis (the constriction of

SECTION 20

#1732787763845

2530-508: Is a process characterized by neuroadaptations that result in reduced drug effects. While receptor upregulation may often play an important role other mechanisms are also known. Tolerance is more pronounced for some effects than for others; tolerance occurs slowly to the effects on mood, itching, urinary retention, and respiratory depression, but occurs more quickly to the analgesia and other physical side effects. However, tolerance does not develop to constipation or miosis (the constriction of

2645-409: Is as follows: In humans, N-demethylation of oxycodone to noroxycodone by CYP3A4 is the major metabolic pathway, accounting for 45% ± 21% of a dose of oxycodone, while O-demethylation of oxycodone into oxymorphone by CYP2D6 and 6-ketoreduction of oxycodone into 6-oxycodols represent relatively minor metabolic pathways, accounting for 11% ± 6% and 8% ± 6% of a dose of oxycodone, respectively. Several of

2760-539: Is associated with increased adverse effects such as "sedation, nausea, vomiting, constipation, urinary retention, and falls". As a result, older adults taking opioids are at greater risk for injury. Opioids do not cause any specific organ toxicity, unlike many other drugs, such as aspirin and paracetamol. They are not associated with upper gastrointestinal bleeding and kidney toxicity . Prescription of opioids for acute low back pain and management of osteoarthritis seem to have long-term adverse effects According to

2875-539: Is associated with increased adverse effects such as "sedation, nausea, vomiting, constipation, urinary retention, and falls". As a result, older adults taking opioids are at greater risk for injury. Opioids do not cause any specific organ toxicity, unlike many other drugs, such as aspirin and paracetamol. They are not associated with upper gastrointestinal bleeding and kidney toxicity . Prescription of opioids for acute low back pain and management of osteoarthritis seem to have long-term adverse effects According to

2990-442: Is better treated with medications other than opioids. Paracetamol and nonsteroidal anti-inflammatory drugs including ibuprofen and naproxen are considered safer alternatives. They are frequently used combined with opioids, such as paracetamol combined with oxycodone ( Percocet ) and ibuprofen combined with hydrocodone ( Vicoprofen ), which boosts the pain relief but is also intended to deter recreational use. Codeine

3105-442: Is better treated with medications other than opioids. Paracetamol and nonsteroidal anti-inflammatory drugs including ibuprofen and naproxen are considered safer alternatives. They are frequently used combined with opioids, such as paracetamol combined with oxycodone ( Percocet ) and ibuprofen combined with hydrocodone ( Vicoprofen ), which boosts the pain relief but is also intended to deter recreational use. Codeine

3220-487: Is closely related to the same mechanism as tolerance. While there is anecdotal claims of benefit with ibogaine , data to support its use in substance dependence is poor. Critical patients who received regular doses of opioids experience iatrogenic withdrawal as a frequent syndrome. Drug addiction is a complex set of behaviors typically associated with misuse of certain drugs, developing over time and with higher drug dosages. Addiction includes psychological compulsion, to

3335-487: Is closely related to the same mechanism as tolerance. While there is anecdotal claims of benefit with ibogaine , data to support its use in substance dependence is poor. Critical patients who received regular doses of opioids experience iatrogenic withdrawal as a frequent syndrome. Drug addiction is a complex set of behaviors typically associated with misuse of certain drugs, developing over time and with higher drug dosages. Addiction includes psychological compulsion, to

3450-451: Is considered to be equivalent in analgesic effect to 30 mg of morphine, while extended release oxycodone is considered to be twice as potent as oral morphine. Similarly to most other opioids, oxycodone increases prolactin secretion, but its influence on testosterone levels is unknown. Unlike morphine, oxycodone lacks immunosuppressive activity (measured by natural killer cell activity and interleukin 2 production in vitro );

3565-428: Is due to gastric stasis (large volume vomiting, brief nausea relieved by vomiting, oesophageal reflux, epigastric fullness, early satiation), besides direct action on the chemoreceptor trigger zone of the area postrema , the vomiting centre of the brain. Vomiting can thus be prevented by prokinetic agents ( e.g. domperidone or metoclopramide ). If vomiting has already started, these drugs need to be administered by

Oxycodone - Misplaced Pages Continue

3680-428: Is due to gastric stasis (large volume vomiting, brief nausea relieved by vomiting, oesophageal reflux, epigastric fullness, early satiation), besides direct action on the chemoreceptor trigger zone of the area postrema , the vomiting centre of the brain. Vomiting can thus be prevented by prokinetic agents ( e.g. domperidone or metoclopramide ). If vomiting has already started, these drugs need to be administered by

3795-718: Is essentially an oxycodone analogue of the morphine-based " twilight sleep ", with ephedrine added to reduce circulatory and respiratory effects. The drug became known as the "Miracle Drug of the 1930s" in Continental Europe and elsewhere and it was the Wehrmacht 's choice for a battlefield analgesic for a time. The drug was expressly designed to provide what the patent application and package insert referred to as "very deep analgesia and profound and intense euphoria" as well as tranquillisation and anterograde amnesia useful for surgery and battlefield wounding cases. Oxycodone

3910-485: Is generally discouraged where that is the case. The weak opioid codeine , in low doses and combined with one or more other drugs, is commonly available in prescription medicines and without a prescription to treat mild pain. Other opioids are usually reserved for the relief of moderate to severe pain. Opioids are effective for the treatment of acute pain (such as pain following surgery). For immediate relief of moderate to severe acute pain, opioids are frequently

4025-485: Is generally discouraged where that is the case. The weak opioid codeine , in low doses and combined with one or more other drugs, is commonly available in prescription medicines and without a prescription to treat mild pain. Other opioids are usually reserved for the relief of moderate to severe pain. Opioids are effective for the treatment of acute pain (such as pain following surgery). For immediate relief of moderate to severe acute pain, opioids are frequently

4140-1141: Is high if a patient has become physically dependent and discontinues oxycodone abruptly. Medically, when the drug has been taken regularly over an extended period, it is withdrawn gradually rather than abruptly. People who regularly use oxycodone recreationally or at higher than prescribed doses are at even higher risk of severe withdrawal symptoms. The symptoms of oxycodone withdrawal, as with other opioids, may include " anxiety , panic attack , nausea , insomnia , muscle pain , muscle weakness , fevers , and other flu-like symptoms ". Withdrawal symptoms have also been reported in newborns whose mothers had been either injecting or orally taking oxycodone during pregnancy. As with other opioids, chronic use of oxycodone (particularly with higher doses) can often cause concurrent hypogonadism (low sex hormone levels). In high doses, overdoses , or in some persons not tolerant to opioids, oxycodone can cause shallow breathing , slowed heart rate , cold/clammy skin, pauses in breathing , low blood pressure , constricted pupils , circulatory collapse , respiratory arrest , and death . In 2011, it

4255-501: Is now rarely used. A related drug, prochlorperazine is more often used, although it has similar risks. Stronger antiemetics such as ondansetron or tropisetron are sometimes used when nausea is severe or continuous and disturbing, despite their greater cost. A less expensive alternative is dopamine antagonists such as domperidone and metoclopramide. Domperidone does not cross the blood–brain barrier and produce adverse central antidopaminergic effects, but blocks opioid emetic action in

4370-501: Is now rarely used. A related drug, prochlorperazine is more often used, although it has similar risks. Stronger antiemetics such as ondansetron or tropisetron are sometimes used when nausea is severe or continuous and disturbing, despite their greater cost. A less expensive alternative is dopamine antagonists such as domperidone and metoclopramide. Domperidone does not cross the blood–brain barrier and produce adverse central antidopaminergic effects, but blocks opioid emetic action in

4485-501: Is properly limited to the natural alkaloids found in the resin of the opium poppy although some include semi-synthetic derivatives. Narcotic , derived from words meaning 'numbness' or 'sleep', as an American legal term, refers to cocaine and opioids, and their source materials; it is also loosely applied to any illegal or controlled psychoactive drug. In some jurisdictions all controlled drugs are legally classified as narcotics . The term can have pejorative connotations and its use

4600-501: Is properly limited to the natural alkaloids found in the resin of the opium poppy although some include semi-synthetic derivatives. Narcotic , derived from words meaning 'numbness' or 'sleep', as an American legal term, refers to cocaine and opioids, and their source materials; it is also loosely applied to any illegal or controlled psychoactive drug. In some jurisdictions all controlled drugs are legally classified as narcotics . The term can have pejorative connotations and its use

4715-416: Is the combination of docusate and bisacodyl. Osmotic laxatives , including lactulose , polyethylene glycol , and milk of magnesia (magnesium hydroxide), as well as mineral oil (a lubricant laxative ), are also commonly used for OIC. Opioid Opioids are a class of drugs that derive from, or mimic, natural substances found in the opium poppy plant. Opioids work in the brain to produce

Oxycodone - Misplaced Pages Continue

4830-412: Is uncertain. Opioids are contraindicated as a first-line treatment for headache because they impair alertness, bring risk of dependence, and increase the risk that episodic headaches will become chronic. Opioids can also cause heightened sensitivity to headache pain. When other treatments fail or are unavailable, opioids may be appropriate for treating headache if the patient can be monitored to prevent

4945-412: Is uncertain. Opioids are contraindicated as a first-line treatment for headache because they impair alertness, bring risk of dependence, and increase the risk that episodic headaches will become chronic. Opioids can also cause heightened sensitivity to headache pain. When other treatments fail or are unavailable, opioids may be appropriate for treating headache if the patient can be monitored to prevent

5060-520: The USCDC , methadone was involved in 31% of opioid related deaths in the US between 1999–2010 and 40% as the sole drug involved, far higher than other opioids. Studies of long term opioids have found that many stop them, and that minor side effects were common. Addiction occurred in about 0.3%. In the United States in 2016 opioid overdose resulted in the death of 1.7 in 10,000 people. Tolerance

5175-406: The USCDC , methadone was involved in 31% of opioid related deaths in the US between 1999–2010 and 40% as the sole drug involved, far higher than other opioids. Studies of long term opioids have found that many stop them, and that minor side effects were common. Addiction occurred in about 0.3%. In the United States in 2016 opioid overdose resulted in the death of 1.7 in 10,000 people. Tolerance

5290-807: The University of Frankfurt in Germany published the first synthesis of oxycodone from thebaine in 1916. When Freund died, in 1920, Speyer wrote his obituary for the German Chemical Society . Speyer, born to a Jewish family in Frankfurt am Main in 1878, became a victim of the Holocaust . He died on 5 May 1942, the second day of deportations from the Lodz Ghetto ; his death was noted in the ghetto's chronicle. The first clinical use of

5405-443: The blood–brain barrier into the central nervous system , and for this reason are only minimally analgesic in comparison. In 1997, a group of Australian researchers proposed (based on a study in rats) that oxycodone acts on KORs, unlike morphine, which acts upon MORs. Further research by this group indicated the drug appears to be a high-affinity κ 2b -opioid receptor agonist. However, this conclusion has been disputed, primarily on

5520-425: The central and peripheral nervous system and the gastrointestinal tract . These receptors mediate both the psychoactive and the somatic effects of opioids. Opioid drugs include partial agonists , like the anti-diarrhea drug loperamide and antagonists like naloxegol for opioid-induced constipation, which do not cross the blood–brain barrier , but can displace other opioids from binding to those receptors in

5635-425: The central and peripheral nervous system and the gastrointestinal tract . These receptors mediate both the psychoactive and the somatic effects of opioids. Opioid drugs include partial agonists , like the anti-diarrhea drug loperamide and antagonists like naloxegol for opioid-induced constipation, which do not cross the blood–brain barrier , but can displace other opioids from binding to those receptors in

5750-546: The chemoreceptor trigger zone . This drug is not available in the U.S. Some antihistamines with anticholinergic properties (e.g. orphenadrine , diphenhydramine ) may also be effective. The first-generation antihistamine hydroxyzine is very commonly used, with the added advantages of not causing movement disorders, and also possessing analgesic-sparing properties. Δ - tetrahydrocannabinol relieves nausea and vomiting; it also produces analgesia that may allow lower doses of opioids with reduced nausea and vomiting. Vomiting

5865-546: The chemoreceptor trigger zone . This drug is not available in the U.S. Some antihistamines with anticholinergic properties (e.g. orphenadrine , diphenhydramine ) may also be effective. The first-generation antihistamine hydroxyzine is very commonly used, with the added advantages of not causing movement disorders, and also possessing analgesic-sparing properties. Δ - tetrahydrocannabinol relieves nausea and vomiting; it also produces analgesia that may allow lower doses of opioids with reduced nausea and vomiting. Vomiting

SECTION 50

#1732787763845

5980-464: The liver mainly via the cytochrome P450 system and is extensive (about 95%) and complex, with many minor pathways and resulting metabolites . Around 10% (range 8–14%) of a dose of oxycodone is excreted essentially unchanged (unconjugated or conjugated ) in the urine . The major metabolites of oxycodone are noroxycodone (70%), noroxymorphone ("relatively high concentrations"), and oxymorphone (5%). The immediate metabolism of oxycodone in humans

6095-1093: The myenteric plexus . Because opioids are addictive and may result in fatal overdose, most are controlled substances . In 2013, between 28 and 38 million people used opioids illicitly (0.6% to 0.8% of the global population between the ages of 15 and 65). In 2011, an estimated 4 million people in the United States used opioids recreationally or were dependent on them. As of 2015, increased rates of recreational use and addiction are attributed to over-prescription of opioid medications and inexpensive illicit heroin . Conversely, fears about overprescribing, exaggerated side effects, and addiction from opioids are similarly blamed for under-treatment of pain. Opioids include opiates , an older term that refers to such drugs derived from opium , including morphine itself. Other opioids are semi-synthetic and synthetic drugs such as hydrocodone , oxycodone , and fentanyl ; antagonist drugs such as naloxone ; and endogenous peptides such as endorphins . The terms opiate and narcotic are sometimes encountered as synonyms for opioid. Opiate

6210-1093: The myenteric plexus . Because opioids are addictive and may result in fatal overdose, most are controlled substances . In 2013, between 28 and 38 million people used opioids illicitly (0.6% to 0.8% of the global population between the ages of 15 and 65). In 2011, an estimated 4 million people in the United States used opioids recreationally or were dependent on them. As of 2015, increased rates of recreational use and addiction are attributed to over-prescription of opioid medications and inexpensive illicit heroin . Conversely, fears about overprescribing, exaggerated side effects, and addiction from opioids are similarly blamed for under-treatment of pain. Opioids include opiates , an older term that refers to such drugs derived from opium , including morphine itself. Other opioids are semi-synthetic and synthetic drugs such as hydrocodone , oxycodone , and fentanyl ; antagonist drugs such as naloxone ; and endogenous peptides such as endorphins . The terms opiate and narcotic are sometimes encountered as synonyms for opioid. Opiate

6325-857: The opium poppy plant. Opioids work in the brain to produce a variety of effects, including pain relief. As a class of substances, they act on opioid receptors to produce morphine -like effects. The terms 'opioid' and 'opiate' are sometimes used interchangeably, but there are key differences based on the manufacturing processes of these medications. Medically they are primarily used for pain relief , including anesthesia . Other medical uses include suppression of diarrhea , replacement therapy for opioid use disorder , reversing opioid overdose , and suppressing cough . Extremely potent opioids such as carfentanil are approved only for veterinary use. Opioids are also frequently used recreationally for their euphoric effects or to prevent withdrawal . Opioids can cause death and have been used for executions in

6440-475: The δ-opioid receptor (DOR) and the κ-opioid receptor (KOR), where it is an agonist similarly. After oxycodone binds to the MOR, a G protein -complex is released, which inhibits the release of neurotransmitters by the cell by decreasing the amount of cAMP produced, closing calcium channels , and opening potassium channels . Opioids like oxycodone are thought to produce their analgesic effects via activation of

6555-511: The μ-opioid receptor . When taken by mouth, it has roughly 1.5 times the effect of the equivalent amount of morphine . Oxycodone was originally produced from the opium poppy opiate alkaloid thebaine in 1916 in Germany. One year later, it was used medically for the first time in Germany in 1917. It is on the World Health Organization's List of Essential Medicines . It is available as a generic medication . In 2022, it

6670-543: The 1990s often would switch their patients to a dosing schedule of once every eight hours when they complained that the duration of action for OxyContin was too short to be taken only twice a day. Mean serum concentration of controlled-release oxycodone peaks at 78 ng/ml at 1 hour and drops to 20 ng/ml at 8 hours and under 10 ng/ml at 12 hours. Purdue strongly discouraged the practice: Purdue's medical director Robert Reder wrote to one doctor in 1995 that "OxyContin has been developed for [12-hour] dosing...I request that you not use

6785-659: The MOR in the midbrain periaqueductal gray (PAG) and rostral ventromedial medulla (RVM). Conversely, they are thought to produce reward and addiction via activation of the MOR in the mesolimbic reward pathway , including in the ventral tegmental area , nucleus accumbens , and ventral pallidum . Tolerance to the analgesic and rewarding effects of opioids is complex and occurs due to receptor-level tolerance (e.g., MOR downregulation ), cellular-level tolerance (e.g., cAMP upregulation), and system-level tolerance (e.g., neural adaptation due to induction of ΔFosB expression). Taken orally, 20 mg of immediate-release oxycodone

6900-512: The MOR, respectively, and MOR activation is 5- to 10-fold less with noroxycodone but 2-fold higher with noroxymorphone relative to oxycodone. Noroxycodone, noroxymorphone, and oxymorphone also have longer biological half-lives than oxycodone. However, despite the greater in vitro activity of some of its metabolites, it has been determined that oxycodone itself is responsible for 83.0% and 94.8% of its analgesic effect following oral and intravenous administration, respectively. Oxymorphone plays only

7015-535: The Neighborhood!" reminded the representatives that their commissions would dramatically increase if they were successful in convincing doctors to prescribe larger doses. Los Angeles Times journalists argue using interviews from opioid addiction experts that such high doses of OxyContin spaced 12 hours apart create a combination of agony during opiate withdrawal (lower lows) and a schedule of reinforcement that relieves this agony fostering addiction. As of 2024,

SECTION 60

#1732787763845

7130-502: The Second World War. The personal notes of Adolf Hitler 's physician, Theodor Morell , indicate Hitler received repeated injections of "Eukodal" (oxycodone; produced by Merck) and Scophedal, as well as Dolantin ( pethidine ) codeine, and morphine less frequently; oxycodone could not be obtained after late January 1945. Opioid Opioids are a class of drugs that derive from, or mimic, natural substances found in

7245-716: The United States . Side effects of opioids may include itchiness , sedation , nausea , respiratory depression , constipation , and euphoria . Long-term use can cause tolerance , meaning that increased doses are required to achieve the same effect, and physical dependence , meaning that abruptly discontinuing the drug leads to unpleasant withdrawal symptoms. The euphoria attracts recreational use, and frequent, escalating recreational use of opioids typically results in addiction. An overdose or concurrent use with other depressant drugs like benzodiazepines commonly results in death from respiratory depression . Opioids act by binding to opioid receptors, which are found principally in

7360-716: The United States . Side effects of opioids may include itchiness , sedation , nausea , respiratory depression , constipation , and euphoria . Long-term use can cause tolerance , meaning that increased doses are required to achieve the same effect, and physical dependence , meaning that abruptly discontinuing the drug leads to unpleasant withdrawal symptoms. The euphoria attracts recreational use, and frequent, escalating recreational use of opioids typically results in addiction. An overdose or concurrent use with other depressant drugs like benzodiazepines commonly results in death from respiratory depression . Opioids act by binding to opioid receptors, which are found principally in

7475-409: The above three accounts for 40% of the metabolism of oxymorphone, making oxymorphone-3-glucuronide the main metabolite of oxymorphone, while the latter two pathways account for less than 10% of the metabolism of oxymorphone. After N-demethylation of oxymorphone, noroxymorphone is further glucuronidated to noroxymorphone-3-glucuronide . Because oxycodone is metabolized by the cytochrome P450 system in

7590-427: The appropriate use of this compound does improve the quality of life of patients with long term chronic pain syndromes. Oxycodone is available as a controlled-release tablet. A 2006 review found that controlled-release oxycodone is comparable to immediate-release oxycodone, morphine , and hydromorphone in management of moderate to severe cancer pain , with fewer side effects than morphine. The author concluded that

7705-741: The basis that oxycodone produces effects that are typical of MOR agonists. In 2006, research by a Japanese group suggested the effect of oxycodone is mediated by different receptors in different situations. Specifically in diabetic mice, the KOR appears to be involved in the antinociceptive effects of oxycodone, while in nondiabetic mice, the μ 1 -opioid receptor seems to be primarily responsible for these effects. Oxycodone can be administered orally, intravenously, via intravenous , intramuscular , or subcutaneous injection . Along with rectal , sublingual , buccal or intranasal drug delivery . The bioavailability of oral administration of oxycodone averages within

7820-475: The benefits and harms should be reassessed at least every three months. In treating chronic pain, opioids are an option to be tried after other less risky pain relievers have been considered, including paracetamol or NSAIDs like ibuprofen or naproxen . Some types of chronic pain, including the pain caused by fibromyalgia or migraine , are preferentially treated with drugs other than opioids. The efficacy of using opioids to lessen chronic neuropathic pain

7935-475: The benefits and harms should be reassessed at least every three months. In treating chronic pain, opioids are an option to be tried after other less risky pain relievers have been considered, including paracetamol or NSAIDs like ibuprofen or naproxen . Some types of chronic pain, including the pain caused by fibromyalgia or migraine , are preferentially treated with drugs other than opioids. The efficacy of using opioids to lessen chronic neuropathic pain

8050-428: The clearance of oxycodone, which may be related to the wide inter-individual variability in its half-life and potency . Ritonavir or lopinavir/ritonavir greatly increase plasma concentrations of oxycodone in healthy human volunteers due to inhibition of CYP3A4 and CYP2D6. Rifampicin greatly reduces plasma concentrations of oxycodone due to strong induction of CYP3A4. There is also a case report of fosphenytoin ,

8165-438: The clinical relevance of this has not been clarified. A few of the metabolites of oxycodone have also been found to be active as MOR agonists, some of which notably have much higher affinity for (as well as higher efficacy at) the MOR in comparison. Oxymorphone possesses 3- to 5-fold higher affinity for the MOR than does oxycodone, while noroxycodone and noroxymorphone possess one-third of and 3-fold higher affinity for

8280-542: The contrary, to protect the reputation of OxyContin as a 12-hour drug and the willingness of health insurance and managed care companies to cover OxyContin despite its high cost relative to generic opiates such as morphine. Purdue sales representatives were instructed to encourage doctors to write prescriptions for larger 12-hour doses instead of more frequent dosing. An August 1996 memo to Purdue sales representatives in Tennessee entitled "$ $ $ $ $ $ $ $ $ $ $ $ $ It's Bonus Time in

8395-643: The controlled-release form is a valid alternative to morphine and a first-line treatment for cancer pain. In 2014, the European Association for Palliative Care recommended oxycodone by mouth as a second-line alternative to morphine by mouth for cancer pain. In children between 11 and 16, the extended-release formulation is FDA-approved for the relief of cancer pain, trauma pain, or pain due to major surgery (for those already treated with opioids, who can tolerate at least 20 mg per day of oxycodone) – this provides an alternative to Duragesic ( fentanyl ),

8510-529: The development of chronic headache. Opioids are being used more frequently in the management of non-malignant chronic pain . This practice has now led to a new and growing problem with addiction and misuse of opioids. Because of various negative effects the use of opioids for long-term management of chronic pain is not indicated unless other less risky pain relievers have been found ineffective. Chronic pain which occurs only periodically, such as that from nerve pain , migraines , and fibromyalgia , frequently

8625-529: The development of chronic headache. Opioids are being used more frequently in the management of non-malignant chronic pain . This practice has now led to a new and growing problem with addiction and misuse of opioids. Because of various negative effects the use of opioids for long-term management of chronic pain is not indicated unless other less risky pain relievers have been found ineffective. Chronic pain which occurs only periodically, such as that from nerve pain , migraines , and fibromyalgia , frequently

8740-513: The dose is reduced abruptly or, specifically in the case of opioids, when an antagonist ( e.g. , naloxone ) or an agonist-antagonist ( e.g. , pentazocine ) is administered. Physical dependence is a normal and expected aspect of certain medications and does not necessarily imply that the patient is addicted. The withdrawal symptoms for opiates may include severe dysphoria , craving for another opiate dose, irritability, sweating , nausea , rhinorrea , tremor , vomiting and myalgia . Slowly reducing

8855-513: The dose is reduced abruptly or, specifically in the case of opioids, when an antagonist ( e.g. , naloxone ) or an agonist-antagonist ( e.g. , pentazocine ) is administered. Physical dependence is a normal and expected aspect of certain medications and does not necessarily imply that the patient is addicted. The withdrawal symptoms for opiates may include severe dysphoria , craving for another opiate dose, irritability, sweating , nausea , rhinorrea , tremor , vomiting and myalgia . Slowly reducing

8970-545: The drug was documented in 1917, the year after it was first developed. It was first introduced to the U.S. market in May 1939. In early 1928, Merck introduced a combination product containing scopolamine , oxycodone, and ephedrine under the German initials for the ingredients SEE, which was later renamed Scophedal (SCOpolamine, ePHEDrine, and eukodAL) in 1942. It was last manufactured in 1987 but can be compounded . This combination

9085-745: The duration of action of OxyContin is 12 hours in "90% of patients". It has never performed any clinical studies in which OxyContin was given at more frequent intervals. In a separate filing, Purdue claims that controlled-release oxycodone "provides pain relief in said patient for at least 12 hours after administration". However, in 2016 an investigation by the Los Angeles Times found that "the drug wears off hours early in many people", inducing symptoms of opiate withdrawal and intense cravings for OxyContin. One doctor, Lawrence Robbins, told journalists that over 70% of his patients would report that OxyContin would only provide 4–7 hours of relief. Doctors in

9200-501: The duration of use. Chronic use of this compound and associated constipation issues can become very serious, and have been implicated in life-threatening bowel perforations , a number of specific medications including naloxegol have been developed to address opioid induced constipation. Oxycodone in combination with naloxone in managed-release tablets has been formulated to both deter abuse and reduce opioid-induced constipation . The risk of experiencing severe withdrawal symptoms

9315-550: The efficacy and safety of these types of preparations. Further tamper resistant medications are currently under consideration with trials for market approval by the FDA. The amount of evidence available only permits making a weak conclusion, but it suggests that a physician properly managing opioid use in patients with no history of substance use disorder can give long-term pain relief with little risk of developing addiction, or other serious side effects. Problems with opioids include

9430-501: The efficacy and safety of these types of preparations. Further tamper resistant medications are currently under consideration with trials for market approval by the FDA. The amount of evidence available only permits making a weak conclusion, but it suggests that a physician properly managing opioid use in patients with no history of substance use disorder can give long-term pain relief with little risk of developing addiction, or other serious side effects. Problems with opioids include

9545-417: The extent that the affected person persists in actions leading to dangerous or unhealthy outcomes. Opioid addiction includes insufflation or injection, rather than taking opioids orally as prescribed for medical reasons. In European nations such as Austria, Bulgaria, and Slovakia, slow-release oral morphine formulations are used in opiate substitution therapy (OST) for patients who do not well tolerate

9660-417: The extent that the affected person persists in actions leading to dangerous or unhealthy outcomes. Opioid addiction includes insufflation or injection, rather than taking opioids orally as prescribed for medical reasons. In European nations such as Austria, Bulgaria, and Slovakia, slow-release oral morphine formulations are used in opiate substitution therapy (OST) for patients who do not well tolerate

9775-436: The following: All of the opioids can cause side effects. Common adverse reactions in patients taking opioids for pain relief include nausea and vomiting, drowsiness , itching, dry mouth, dizziness , and constipation . Tolerance to nausea occurs within 7–10 days, during which antiemetics ( e.g. low dose haloperidol once at night) are very effective. Due to severe side effects such as tardive dyskinesia, haloperidol

9890-436: The following: All of the opioids can cause side effects. Common adverse reactions in patients taking opioids for pain relief include nausea and vomiting, drowsiness , itching, dry mouth, dizziness , and constipation . Tolerance to nausea occurs within 7–10 days, during which antiemetics ( e.g. low dose haloperidol once at night) are very effective. Due to severe side effects such as tardive dyskinesia, haloperidol

10005-447: The immediate metabolites of oxycodone are subsequently conjugated with glucuronic acid and excreted in the urine . 6α-Oxycodol and 6β-oxycodol are further metabolized by N-demethylation to nor-6α-oxycodol and nor-6β-oxycodol , respectively, and by N-oxidation to 6α-oxycodol-N-oxide and 6β-oxycodol-N-oxide (which can subsequently be glucuronidated as well). Oxymorphone is also further metabolized, as follows: The first pathway of

10120-875: The immediate-release formulation. In the United Kingdom, it is available by injection . Combination products are also available with paracetamol (acetaminophen), ibuprofen , naloxone , naltrexone , and aspirin . Common side effects include euphoria , constipation , nausea , vomiting , loss of appetite , drowsiness , dizziness , itching , dry mouth , and sweating . Side effects may also include addiction and dependence , substance abuse , irritability , depression or mania , delirium , hallucinations , hypoventilation , gastroparesis , bradycardia , and hypotension . Those allergic to codeine may also be allergic to oxycodone. Use of oxycodone in early pregnancy appears relatively safe. Opioid withdrawal may occur if rapidly stopped. Oxycodone acts by activating

10235-502: The individual. Oxycodone has a volume of distribution of 2.6L/kg, in the blood it is distributed to skeletal muscle , liver, intestinal tract, lungs, spleen , and brain. At equilibrium the unbound concentration in the brain is threefold higher than the unbound concentration in blood. Conventional oral preparations start to reduce pain within 10 to 15 minutes on an empty stomach; in contrast, OxyContin starts to reduce pain within one hour. The metabolism of oxycodone in humans occurs in

10350-536: The intake of opioids over days and weeks can reduce or eliminate the withdrawal symptoms. The speed and severity of withdrawal depends on the half-life of the opioid; heroin and morphine withdrawal occur more quickly than methadone withdrawal. The acute withdrawal phase is often followed by a protracted phase of depression and insomnia that can last for months. The symptoms of opioid withdrawal can be treated with other medications, such as clonidine . Physical dependence does not predict drug misuse or true addiction, and

10465-536: The intake of opioids over days and weeks can reduce or eliminate the withdrawal symptoms. The speed and severity of withdrawal depends on the half-life of the opioid; heroin and morphine withdrawal occur more quickly than methadone withdrawal. The acute withdrawal phase is often followed by a protracted phase of depression and insomnia that can last for months. The symptoms of opioid withdrawal can be treated with other medications, such as clonidine . Physical dependence does not predict drug misuse or true addiction, and

10580-616: The literature found that opioids were not necessarily more effective in treating shortness of breath in patients who have advanced cancer. Though not typically a first line of treatment, opioids, such as oxycodone and methadone , are sometimes used in the treatment of severe and refractory restless legs syndrome . Hyperalgesia Opioid-induced hyperalgesia (OIH) has been evident in patients after chronic opioid exposure. Common and short term Other Each year 69,000 people worldwide die of opioid overdose, and 15 million people have an opioid addiction. In older adults, opioid use

10695-616: The literature found that opioids were not necessarily more effective in treating shortness of breath in patients who have advanced cancer. Though not typically a first line of treatment, opioids, such as oxycodone and methadone , are sometimes used in the treatment of severe and refractory restless legs syndrome . Hyperalgesia Opioid-induced hyperalgesia (OIH) has been evident in patients after chronic opioid exposure. Common and short term Other Each year 69,000 people worldwide die of opioid overdose, and 15 million people have an opioid addiction. In older adults, opioid use

10810-469: The liver, its pharmacokinetics can be influenced by genetic polymorphisms and drug interactions concerning this system, as well as by liver function . Some people are fast metabolizers of oxycodone, while others are slow metabolizers , resulting in polymorphism-dependent alterations in relative analgesia and toxicity. While higher CYP2D6 activity increases the effects of oxycodone (owing to increased conversion into oxymorphone), higher CYP3A4 activity has

10925-471: The most suitable drug for a particular patient. Otherwise, treatment with CNS stimulants is generally effective. Itching tends not to be a severe problem when opioids are used for pain relief, but antihistamines are useful for counteracting itching when it occurs. Non-sedating antihistamines such as fexofenadine are often preferred as they avoid increasing opioid induced drowsiness. However, some sedating antihistamines such as orphenadrine can produce

11040-471: The most suitable drug for a particular patient. Otherwise, treatment with CNS stimulants is generally effective. Itching tends not to be a severe problem when opioids are used for pain relief, but antihistamines are useful for counteracting itching when it occurs. Non-sedating antihistamines such as fexofenadine are often preferred as they avoid increasing opioid induced drowsiness. However, some sedating antihistamines such as orphenadrine can produce

11155-542: The only other extended-release opioid analgesic approved for children. Oxycodone, in its extended-release form and/or in combination with naloxone , is sometimes used off-label in the treatment of severe and refractory restless legs syndrome . Oxycodone is available in a variety of formulations for by mouth or under the tongue : In the US, oxycodone is only approved for use by mouth, available as tablets and oral solutions. Parenteral formulations of oxycodone (brand name OxyNorm) are also available in other parts of

11270-400: The opposite effect and decreases the effects of oxycodone (owing to increased metabolism into noroxycodone and noroxymorphone). The dose of oxycodone must be reduced in patients with reduced liver function . The clearance of oxycodone is 0.8 L/min. Oxycodone and its metabolites are mainly excreted in urine. Therefore, oxycodone accumulates in patients with kidney impairment. Oxycodone

11385-442: The prescribing information for OxyContin still specifies a 12-hour dosing schedule as the only option; it also states, "there are no well-controlled clinical studies evaluating the safety and efficacy with dosing more frequently than every 12 hours." Oxycodone's chemical name is derived from codeine . The chemical structures are very similar, differing only in that It is also similar to hydrocodone , differing only in that it has

11500-425: The pupil of the eye to less than or equal to two millimeters). This idea has been challenged, however, with some authors arguing that tolerance does develop to miosis. Tolerance to opioids is attenuated by a number of substances, including: Tolerance is a physiologic process where the body adjusts to a medication that is frequently present, usually requiring higher doses of the same medication over time to achieve

11615-425: The pupil of the eye to less than or equal to two millimeters). This idea has been challenged, however, with some authors arguing that tolerance does develop to miosis. Tolerance to opioids is attenuated by a number of substances, including: Tolerance is a physiologic process where the body adjusts to a medication that is frequently present, usually requiring higher doses of the same medication over time to achieve

11730-399: The same effect. It is a common occurrence in individuals taking high doses of opioids for extended periods, but does not predict any relationship to misuse or addiction. Physical dependence is the physiological adaptation of the body to the presence of a substance, in this case opioid medication. It is defined by the development of withdrawal symptoms when the substance is discontinued, when

11845-399: The same effect. It is a common occurrence in individuals taking high doses of opioids for extended periods, but does not predict any relationship to misuse or addiction. Physical dependence is the physiological adaptation of the body to the presence of a substance, in this case opioid medication. It is defined by the development of withdrawal symptoms when the substance is discontinued, when

11960-532: The side effects of buprenorphine or methadone . Buprenorphine can also be used together with naloxone for a longer treatment of addiction. In other European countries including the UK, this is also legally used for OST although on a varying scale of acceptance. Slow-release formulations of medications are intended to curb misuse and lower addiction rates while trying to still provide legitimate pain relief and ease of use to pain patients. Questions remain, however, about

12075-484: The side effects of buprenorphine or methadone . Buprenorphine can also be used together with naloxone for a longer treatment of addiction. In other European countries including the UK, this is also legally used for OST although on a varying scale of acceptance. Slow-release formulations of medications are intended to curb misuse and lower addiction rates while trying to still provide legitimate pain relief and ease of use to pain patients. Questions remain, however, about

12190-435: The treatment of acute cough does not recommend its use. (The opioid analogue dextromethorphan , long claimed to be as effective a cough suppressant as codeine, has similarly demonstrated little benefit in several recent studies. ) Low dose morphine may help chronic cough but its use is limited by side effects. In cases of diarrhea-predominate irritable bowel syndrome , opioids may be used to suppress diarrhea. Loperamide

12305-435: The treatment of acute cough does not recommend its use. (The opioid analogue dextromethorphan , long claimed to be as effective a cough suppressant as codeine, has similarly demonstrated little benefit in several recent studies. ) Low dose morphine may help chronic cough but its use is limited by side effects. In cases of diarrhea-predominate irritable bowel syndrome , opioids may be used to suppress diarrhea. Loperamide

12420-509: The treatment of choice due to their rapid onset, efficacy and reduced risk of dependence. However, a new report showed a clear risk of prolonged opioid use when opioid analgesics are initiated for an acute pain management following surgery or trauma. They have also been found to be important in palliative care to help with the severe, chronic, disabling pain that may occur in some terminal conditions such as cancer, and degenerative conditions such as rheumatoid arthritis . In many cases opioids are

12535-509: The treatment of choice due to their rapid onset, efficacy and reduced risk of dependence. However, a new report showed a clear risk of prolonged opioid use when opioid analgesics are initiated for an acute pain management following surgery or trauma. They have also been found to be important in palliative care to help with the severe, chronic, disabling pain that may occur in some terminal conditions such as cancer, and degenerative conditions such as rheumatoid arthritis . In many cases opioids are

12650-1337: The world, however, and are widely used in the European Union. In Spain , the Netherlands and the United Kingdom , oxycodone is approved for intravenous (IV) and intramuscular (IM) use. When first introduced in Germany during World War I , both IV and IM administrations of oxycodone were commonly used for postoperative pain management of Central Powers soldiers. Most common side effects of oxycodone include reduced sensitivity to pain, delayed gastric emptying, euphoria , anxiolysis (a reduction in anxiety), feelings of relaxation , and respiratory depression . Common side effects of oxycodone include constipation (23%), nausea (23%), vomiting (12%), somnolence (23%), dizziness (13%), itching (13%), dry mouth (6%), and sweating (5%). Less common side effects (experienced by less than 5% of patients) include loss of appetite , nervousness , abdominal pain , diarrhea , urinary retention , dyspnea , and hiccups . Most side effects generally become less intense over time, although issues related to constipation are likely to continue for

12765-470: Was allegedly chosen over other common opiates for this product because it had been shown to produce less sedation at equianalgesic doses compared to morphine, hydromorphone (Dilaudid), and hydrocodone (Dicodid). During Operation Himmler , Skophedal was also reportedly injected in massive overdose into the prisoners dressed in Polish Army uniforms in the staged incident on 1 September 1939 which opened

12880-424: Was once viewed as the "gold standard" in cough suppressants , but this position is now questioned. Some recent placebo -controlled trials have found that it may be no better than a placebo for some causes including acute cough in children. As a consequence, it is not recommended for children. Additionally, there is no evidence that hydrocodone is useful in children. Similarly, a 2012 Dutch guideline regarding

12995-424: Was once viewed as the "gold standard" in cough suppressants , but this position is now questioned. Some recent placebo -controlled trials have found that it may be no better than a placebo for some causes including acute cough in children. As a consequence, it is not recommended for children. Additionally, there is no evidence that hydrocodone is useful in children. Similarly, a 2012 Dutch guideline regarding

13110-449: Was the 60th most commonly prescribed medication in the United States, with more than 11   million prescriptions. A number of abuse-deterrent formulations are available, such as in combination with naloxone or naltrexone . Oxycodone is used for managing moderate to severe acute or chronic pain when other treatments are not sufficient. It may improve quality of life in certain types of pain. Numerous studies have been completed, and

13225-716: Was the leading cause of drug-related deaths in the U.S. However, from 2012 onwards, heroin and fentanyl have become more common causes of drug-related deaths. Oxycodone overdose has also been described to cause spinal cord infarction in high doses and ischemic damage to the brain , due to prolonged hypoxia from suppressed breathing. Oxycodone is metabolized by the enzymes CYP3A4 and CYP2D6 . Therefore, its clearance can be altered by inhibitors and inducers of these enzymes, increasing and decreasing half-life , respectively. (For lists of CYP3A4 and CYP2D6 inhibitors and inducers, see here and here , respectively.) Natural genetic variation in these enzymes can also influence

#844155